Niloofar Rahmani

Array ( [id] => 330560 [patent_doc_number] => 07511056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'TGF-β inhibitors' [patent_app_type] => utility [patent_app_number] => 11/577094 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9762 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511056.pdf [firstpage_image] =>[orig_patent_app_number] => 11577094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829185 [patent_doc_number] => 20060063796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Pyrazoles as inhibitors of tumor necrosis factor' [patent_app_type] => utility [patent_app_number] => 11/264063 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92998 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063796.pdf [firstpage_image] =>[orig_patent_app_number] => 11264063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4981 [patent_doc_number] => 07812166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/261814 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21348 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812166.pdf [firstpage_image] =>[orig_patent_app_number] => 11261814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777454 [patent_doc_number] => 20060106094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Synthetic discodermolide analogs' [patent_app_type] => utility [patent_app_number] => 11/261686 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106094.pdf [firstpage_image] =>[orig_patent_app_number] => 11261686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808397 [patent_doc_number] => 20060094752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Substituted indolizines and derivatives as CNS agents' [patent_app_type] => utility [patent_app_number] => 11/260716 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10747 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094752.pdf [firstpage_image] =>[orig_patent_app_number] => 11260716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231568 [patent_doc_number] => 20070293676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method for Separation and Purification of Hydrocodone by Preparative Chromatography' [patent_app_type] => utility [patent_app_number] => 11/576059 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4148 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293676.pdf [firstpage_image] =>[orig_patent_app_number] => 11576059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166251 [patent_doc_number] => 20070287838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Imidazo[4,5-B]Pyridin-2-One and Oxazolo[4,5-B]Pyridin-2-One Compounds and Analogs Thereof as Therapeutic Compounds' [patent_app_type] => utility [patent_app_number] => 11/665640 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59590 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287838.pdf [firstpage_image] =>[orig_patent_app_number] => 11665640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743653 [patent_doc_number] => 20060089378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Tetrahydro-pyridinyl pyrazole cannabinoid modulators' [patent_app_type] => utility [patent_app_number] => 11/253127 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30483 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089378.pdf [firstpage_image] =>[orig_patent_app_number] => 11253127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705195 [patent_doc_number] => 20080064719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Crf Receptor Antagonists And Methods Relating Thereto' [patent_app_type] => utility [patent_app_number] => 11/576954 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12681 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064719.pdf [firstpage_image] =>[orig_patent_app_number] => 11576954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716208 [patent_doc_number] => 20060079571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel' [patent_app_type] => utility [patent_app_number] => 11/244171 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2818 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079571.pdf [firstpage_image] =>[orig_patent_app_number] => 11244171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131794 [patent_doc_number] => 07700583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => '11β-hydroxysteroid dehydrogenase type 1 active compounds' [patent_app_type] => utility [patent_app_number] => 11/244745 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21651 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700583.pdf [firstpage_image] =>[orig_patent_app_number] => 11244745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356316 [patent_doc_number] => 07488752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Thrombin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/243708 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17799 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488752.pdf [firstpage_image] =>[orig_patent_app_number] => 11243708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477646 [patent_doc_number] => 07906528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/664565 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39741 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906528.pdf [firstpage_image] =>[orig_patent_app_number] => 11664565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881472 [patent_doc_number] => 20060030555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Novel imidazopyridines as cyclin dependent kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/238597 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12724 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030555.pdf [firstpage_image] =>[orig_patent_app_number] => 11238597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833642 [patent_doc_number] => 07396932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones' [patent_app_type] => utility [patent_app_number] => 11/235510 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13874 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396932.pdf [firstpage_image] =>[orig_patent_app_number] => 11235510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843852 [patent_doc_number] => 07388096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Crystalline forms of a factor Xa inhibitor' [patent_app_type] => utility [patent_app_number] => 11/235519 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15356 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/388/07388096.pdf [firstpage_image] =>[orig_patent_app_number] => 11235519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596923 [patent_doc_number] => 20060160841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Crystallization via high-shear transformation' [patent_app_type] => utility [patent_app_number] => 11/235327 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3741 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160841.pdf [firstpage_image] =>[orig_patent_app_number] => 11235327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910292 [patent_doc_number] => 20080021059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 11/576538 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32552 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021059.pdf [firstpage_image] =>[orig_patent_app_number] => 11576538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121859 [patent_doc_number] => 07709518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Compounds for inflammation and immune-related uses' [patent_app_type] => utility [patent_app_number] => 11/233224 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29772 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709518.pdf [firstpage_image] =>[orig_patent_app_number] => 11233224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133036 [patent_doc_number] => 07696224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases' [patent_app_type] => utility [patent_app_number] => 11/665183 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16986 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696224.pdf [firstpage_image] =>[orig_patent_app_number] => 11665183 [rel_patent_id] =>[rel_patent_doc_number] =>)